Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Burton J. Goldstein"'
Autor:
Burton J. Goldstein, Paul J. Goodnick
Publikováno v:
Journal of Psychopharmacology. 12:S21-S54
Since their introduction, the selective serotonin reuptake inhibitors (SSRIs) have become one of the most widely used classes of medication in psychiatry. Their popularity is based on apparent efficacy over a wide range of disorders and a favorable s
The objective of this study is to examine the relationship between depression and drug use and potential ramifications of that relationship on the health services needs, utilization, and costs of chronic and injecting drug abusers. A network-based sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f6b05b9bc66c48269c99a8dbf3d197c
https://doi.org/10.1016/s1057-6290(00)80005-4
https://doi.org/10.1016/s1057-6290(00)80005-4
Autor:
Burton J. Goldstein, Paul J. Goodnick
Publikováno v:
Journal of psychopharmacology (Oxford, England). 12(3 Suppl)
The clinical use of tricyclic antidepressants (TCAs) is often complicated by toxicity and safety problems due to their effects on multiple mechanisms of action, many of which are unnecessary for therapeutic effect. The development of the selective se
Autor:
Burton J. Goldstein, Paul J. Goodnick
Publikováno v:
Journal of psychopharmacology (Oxford, England). 12(3 Suppl)
The selective serotonin reuptake inhibitors (SSRIs), citalopram, fluoxetine, fluvoxamine, paroxetine and sertraline, are the result of rational research to find drugs that were as effective as the tricyclic antidepressants but with fewer safety and t
Autor:
Burton J. Goldstein
Publikováno v:
Neuropsychopharmacology. 29:1027-1027
Autor:
Burton J. Goldstein
Publikováno v:
Journal of Psychopharmacology. 12:S3-S3
Autor:
Bernhard Huitfeldt, James Claghorn, Burton J. Goldstein, Stefan Behrnetz, Daniel F. Bush, Samuel Gershon
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 7:367-382
1. 1. This paper presents the results from a large multicenter study, performed at three clinical research units in the USA. Prior to a three to seven days of placebo washout period, patients were randomly assigned to zimelidine, a potent and selecti
Publikováno v:
Clinical Pharmacology and Therapeutics. 37:674-679
Fifty-nine outpatients with insomnia were treated in a 3-week study to assess the safety and efficacy of a new triazolothienodiazepine with a short t1/2, brotizolam. Therapy was initiated with 0.25 mg at night, but by the end of the study all subject
Publikováno v:
The Journal of Clinical Pharmacology. 14:455-463
Publikováno v:
Journal of Clinical Psychology. 34:677-685
The similarities in structure and usage of two widely used adjective checklists, the Profile of Mood States (POMS) and Symptom Checklist (SCL), suggested the feasibility of pooling the items from the two scales into a single factor analysis. This pro